Cortical cell orientation selectivity fails to develop in the absence of ON-center retinal ganglion cell activity.
Neuronal activity is necessary for the normal development of visual cortical cell receptive fields. When neuronal activity is blocked, cortical cells fail to develop normal ocular dominance and orientation selectivity. Patterned activity has been shown to play an instructive, rather than merely permissive, role in the segregation of geniculocortical afferents into ocular dominance columns. To test whether normal patterns of activity are necessary to instruct the development of cortical orientation selectivity, we studied ferrets raised without ON-center retinal ganglion cell activity. The ON-center blockade was produced by daily intravitreal injections of DL-2-amino-4-phosphonobutyric acid (APB). Effects of this treatment on the development of orientation selectivity in primary visual cortex were assessed using extracellular electrode recordings and optical imaging. In animals raised with an ON-center blockade starting after visual cortical cells are visually driven but still poorly tuned for orientation, cortical cell responsivity was maintained, but no maturation of orientation selectivity was seen. No recovery of orientation tuning was seen in animals treated with APB during the normal period of orientation development and then allowed several months of development without treatment. These results suggest that patterns of neuronal activity carried in the separate ON- and OFF-center visual pathways are necessary for the development of orientation selectivity in visual cortical neurons of the ferret and that there is a critical period for this development.
Chapman
B
B
Center for Neuroscience, University of California, Davis, California 95616, USA. bxchapman@ucdavis.edu
Gödecke
I
I
D000613:Aminobutyrates / Q000494:pharmacology; D000818:Animals; D003423:Critical Period, Psychological; D004594:Electrophysiology; D018690:Excitatory Amino Acid Agonists / Q000494:pharmacology; D005260:Female; D005289:Ferrets; D007267:Injections; D010364:Pattern Recognition, Visual / Q000502:physiology; D011247:Pregnancy; D012165:Retinal Ganglion Cells / Q000187:drug effects / Q000502:physiology*; D015348:Vision, Binocular / Q000502:physiology; D014793:Visual Cortex / Q000166:cytology / Q000254:growth & development*; D014795:Visual Pathways / Q000166:cytology / Q000187:drug effects / Q000502:physiology; D014822:Vitreous Body
D000613:Aminobutyrates; D018690:Excitatory Amino Acid Agonists; C012729:2-amino-4-phosphonobutyric acid